pnb-0408 dihexa clinical trial What if neuroplasticity research targeted the HGF/c-Met pathway? (PNB -0408) is an angiotensin IV–derived peptide studied in preclinical models for its role in synaptogenesis and cognitive signaling mechanisms. Human data remains limited Dihexa | | 1401708-83-5 |
Dihexa 1401708 83 5 AdooQ Dihexa (PNB 0408) Dosing, Side Effects, FDA Status & Research PeptIQ PeptIQ dihexa human trials Dihexa (also known as PNB 0408) is an experimental small molecule derived from Dihexa (PNB 0408) Angiotensin IV analogue CAS NO.:1401708 83 5 GlpBio Dihexa UK: Evidence Based Peptide Research Guide
Pay in 4 interest-free payments of $5.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19



